In collaboration with the Community-Based Research Centre, we received a $300000 CAD grant to conduct formative research on planning for long-acting PrEP options in Canada. Read more about the funded grants in this competition here.
In collaboration with the Community-Based Research Centre, we received a $300000 CAD grant to conduct formative research on planning for long-acting PrEP options in Canada. Read more about the funded grants in this competition here.
Oscar’s research on Reasons for declining PrEP, part of the PRIMP project, received a Trainee Award and will be presented at the major infectious diseases conference ID Week at the end of September 2021. Congratulations Oscar! See the conference webpage here.
Robinson Truong has been awarded the Li Ka Shing Excellence Award!
You can read more about it here!
Darrell has been appointed a Tier 2 Canada Research Chair in HIV Prevention and STI Research. More information can be found here.
As of June 25, 2020, the Options Lab received federal funding for a COVID-19 clinical trial which aims to investigate if a 14 day course of oral Kaletra (lopinavir/ritonavir), which is currently used as one strategy for HIV post-exposure prophylaxis (PEP), is effective as COVID-19 PEP. More information can be found here.
As of June 8, 2020, Darrell has been elected to the Governing Council of the International AIDS Society (IAS). You can read more about this here.
Darrell sat down with the folks at CATIE to discuss PrEP and the publication of Canada’s first PrEP and nPEP Guidelines in CMAJ.
Darrell spoke with the Globe and Mail about the PrEP and nPEP guidelines and the importance of educating more providers about PrEP to support scale-up. “Because PrEP is so effective in treating HIV, the goal is that by increasing uptake, we could actually move Canada towards a reduction in the rate of HIV infections every […]
Darrell provided his perspective to CBC News on what factors are at play in rising STI rates in Canada. You can read more here.
Recent Comments